SCHEMBL2069217

SCHEMBL2069217

[O-]/[N+](=C/C=Cc1ccccc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 1.00
RAB9A P51151 3/20 1.00
MAOB P27338 1/20 0.52
NFE2L2 Q16236 1/20 0.47
FBP1 P09467 1/20 0.45
ALDH1A1 P00352 7/20 0.45
MAPK1 P28482 2/20 0.45
LMNA P02545 2/20 0.45
TRPA1 O75762 1/20 0.45
ALOX5 P09917 1/20 0.45
MAPT P10636 6/20 0.44
G6PD P11413 2/20 0.44
RECQL P46063 2/20 0.44
ALOX15 P16050 2/20 0.44
TSHR P16473 1/20 0.44
APP P05067 1/20 0.39
POLB P06746 1/20 0.38
CYP19A1 P11511 1/20 0.38
CYP1B1 Q16678 1/20 0.38
CHAT P28329 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2998732 1.00 NPC1 (1.00) NPC1RAB9AMAOBNFE2L2FBP1
SCHEMBL13164321 1.00 NPC1 (1.00) NPC1RAB9AMAOBNFE2L2FBP1
SCHEMBL12349220 0.83 RAB9A (0.70) NPC1RAB9AALDH1A1MAPK1LMNA
SCHEMBL2995976 0.83 RAB9A (0.70) NPC1RAB9AALDH1A1MAPK1LMNA
Hydrochloric Acid SCHEMBL3390220 0.82 RAB9A (0.68) NPC1RAB9AALDH1A1MAPK1LMNA
SCHEMBL7972788 0.79 NPC1 (0.64) NPC1RAB9AALDH1A1MAPK1LMNA
SCHEMBL12411092 0.75 NPC1 (0.60) NPC1RAB9AMAOBNFE2L2ALDH1A1
SCHEMBL7972705 0.73 NPC1 (0.57) NPC1RAB9ANFE2L2ALDH1A1MAPK1
SCHEMBL12349218 0.73 ALDH1A1 (0.73) NPC1RAB9ANFE2L2FBP1ALDH1A1
SCHEMBL264277 0.73 ALDH1A1 (0.73) NPC1RAB9ANFE2L2FBP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166170-A1 SYNTHESIS OF AVRAINVILLAMIDE, STEPHACIDIN B, AND ANALOGUES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-07-07 US disclosed
US-7902196-B2 Synthesis of avrainvillamide, strephacidin B, and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-03-08 US disclosed
US-20090143581-A1 SYNTHESIS OF AVRAINVILLAMIDE, STREPHACIDIN B, AND ANALOGUES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2009-06-04 US disclosed
US-3988159-A Light-sensitive material containing nitrone for forming heat-fixed images AMERICAN CAN COMPANY (US) 1976-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166170-A1 SYNTHESIS OF AVRAINVILLAMIDE, STEPHACIDIN B, AND ANALOGUES THEREOF MDN1, VASP, ATRIP NPC1 3731/4885RAB9A 1761/4885MAOB 2163/4885
US-20090143581-A1 SYNTHESIS OF AVRAINVILLAMIDE, STREPHACIDIN B, AND ANALOGUES THEREOF MDN1, BIRC3, STAMBP NPC1 3752/4885RAB9A 2439/4885MAOB 2402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.